World's Best Scientists 2026 revealed!
Brunangelo Falini

Brunangelo Falini

Award Badge
Medicine
Italy
2023

D-Index & Metrics

Medicine

D-Index
124
Citations
73651
World Ranking
3169
National Ranking
88

Research.com Recognitions

  • 2023 - Research.com Medicine in Italy Leader Award

Overview

Brunangelo Falini is a researcher affiliated with the University of Perugia in Italy, with extensive work in medicine, particularly within hematology and related subfields. Their research spans across molecular biology, genetics, oncology, and pathology, with a strong focus on blood cancers and disorders.

The scientist's main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

More specifically, their work involves key subfields such as:

  • Molecular Biology
  • Hematology
  • Genetics
  • Oncology
  • Pathology and Forensic Medicine

Falini's major topics of research cover a variety of hematologic malignancies and therapeutic strategies, including:

  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • CAR-T cell therapy research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Immune Cell Function and Interaction
  • Protein Degradation and Inhibitors

Among frequently published venues, the scientist has contributed extensively to journals such as:

  • Blood
  • Leukemia
  • Hematological Oncology
  • American Journal of Hematology
  • Haematologica

Some recent papers authored or coauthored by Falini include:

  • "NPM1-mutated acute myeloid leukemia: from bench to bedside," 2020, Blood
  • "The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee," 2022, Blood
  • "Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study," 2020, The Lancet Haematology
  • "Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia," 2022, Blood
  • "Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia," 2021, New England Journal of Medicine

Frequent co-authors in Falini's work include:

  • Enrico Tiacci
  • Maria Paola Martelli
  • Vincenzo Maria Perriello
  • Andrea Marra
  • Lorenzo Brunetti

Best Publications

  • A revised European-American classification of lymphoid neoplasms : a proposal from the international lymphoma study group

    NL Harris;ES Jaffe;H Stein;PM Banks

  • Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

    Christine P. Hans;Dennis D. Weisenburger;Timothy C. Greiner;Randy D. Gascoyne

  • Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

    J. L. Cordell;B. Falini;W. N. Erber;A. K. Ghosh

  • The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

    H Stein;DY Mason;J Gerdes;N O'Connor

  • Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype

    Brunangelo Falini;Christina Mecucci;Enrico Tiacci;Myriam Alcalay

  • Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

    Mauro Di Ianni;Mauro Di Ianni;Franca Falzetti;Alessandra Carotti;Adelmo Terenzi

  • BRAF mutations in hairy-cell leukemia

    Enrico Tiacci;Vladimir Trifonov;Gianluca Schiavoni;Antony Holmes

  • CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

    Harald Stein;Hans-Dieter Foss;Horst Dürkop;Theresa Marafioti

  • Nucleophosmin and cancer

    Silvia Grisendi;Cristina Mecucci;Brunangelo Falini;Pier Paolo Pandolfi

  • Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

    Susanne Schnittger;Claudia Schoch;Wolfgang Kern;Cristina Mecucci

  • Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases

    S. A. Pileri;T. M. Grogan;N. L. Harris;P Banks

  • ALK+ Lymphoma: Clinico-Pathological Findings and Outcome

    Brunangelo Falini;Stefano Pileri;Pier Luigi Zinzani;Antonino Carbone

  • Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients.

    S A Pileri;S Ascani;M C Cox;C Campidelli

  • Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.

    Brunangelo Falini;Ildo Nicoletti;Massimo Fabrizio Martelli;Cristina Mecucci

  • BCL-6 protein is expressed in germinal-center B cells

    Giorgio Cattoretti;Chih Chao Chang;Katarina Cechova;Jiandong Zhang

  • Nucleophosmin regulates the stability and transcriptional activity of p53.

    Emanuela Colombo;Jean Christophe Marine;Davide Danovi;Brunangelo Falini

  • Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

    Lluı́s Colomo;Armando López-Guillermo;Armando López-Guillermo;Marı́a Perales;Marı́a Perales;Susana Rives;Susana Rives

  • Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin

    Ramiro Garzon;Michela Garofalo;Maria Paola Martelli;Roger Briesewitz

  • CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.

    B Falini;S Pileri;G Pizzolo;H Durkop

  • A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells

    Brunangelo Falini;Marco Fizzotti;Alessandra Pucciarini;Barbara Bigerna

Frequent Co-Authors

Stefano Pileri
Stefano Pileri European Institute of Oncology
Massimo F. Martelli
Massimo F. Martelli University of Perugia
Pier Luigi Zinzani
Pier Luigi Zinzani University of Bologna
Pier Giuseppe Pelicci
Pier Giuseppe Pelicci European Institute of Oncology
Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro
Laura Pasqualucci
Laura Pasqualucci Columbia University
Giorgio Inghirami
Giorgio Inghirami Cornell University
Harald Stein
Harald Stein Charité - University Medicine Berlin
Karen Pulford
Karen Pulford University of Oxford
Torsten Haferlach
Torsten Haferlach MLL Munich Leukemia Laboratory

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in Medicine doesn’t have to follow a traditional path. Online programs now make it easier to pursue health-related degrees and advance professionally while maintaining flexibility. For registered nurses looking to upskill, rn to np programs online allow you to transition from RN roles to nurse practitioners without pausing your career.

The demand for nutrition experts is also rising. If you’re passionate about health and wellness, online nutrition degree programs offer robust curricula rooted in science, policy, and counseling—delivered entirely online.

Those interested in the business side of healthcare should consider a graduate-level degree. Knowing how to evaluate healthcare administration degree programs is crucial for choosing accredited programs that prepare you for senior leadership positions.

Finally, many RNs want to pursue a bachelor’s degree without stepping away from clinical roles. rn to bsn programs now offer flexible options, including those with no additional clinical requirements.

Best Scientists Citing Brunangelo Falini

Trending Scientists